Antibiotics for treating scrub typhus

doi:10.1002/14651858.CD002150

Intervention Review

You have free access to this content

Antibiotics for treating scrub typhus

Qin Liu²,
Ratana Panpanich^1,*

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 25 MAY 2010

DOI: 10.1002/14651858.CD002150

Database Title

The Cochrane Library

Additional Information

How to Cite

Liu Q, Panpanich R. Antibiotics for treating scrub typhus. Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD002150. DOI: 10.1002/14651858.CD002150.

Author Information

¹
Faculty of Medicine, Community Medicine, Chiang Mai, North, Thailand
²
School of Public Health, Chongqing Medical University, Effective Healthcare Research Programme Consortium China (Chongqing) RPC Programme, Chongqing, China

^*Ratana Panpanich, Community Medicine, Faculty of Medicine, Chiang Mai University, 110 Intawaroros, Chiang Mai, North, 50200, Thailand. rpanpani@mail.med.cmu.ac.th.

Publication History

Publication Status: New search for studies and content updated (no change to conclusions)
Published Online: 21 JAN 2009

ARTICLE TOOLS

View Full Article (HTML) Summary (55K)Standard (284K)Full (345K)

	Figure 1. Forest plot of comparison: 1 Tetracycline vs chloramphenicol, outcome: 1.1 Febrile after 48 hours.
	Figure 2. Forest plot of comparison: 2 Doxycycline vs tetracycline, outcome: 2.1 Febrile after 48 hours.
	Figure 3. Forest plot of comparison: 3 Rifampicin vs doxycycline, outcome: 3.1 Febrile after 48 hours.
	Figure 4. Forest plot of comparison: 6 Azithromycin vs doxycycline, outcome: 6.1 Febrile after 48 hours.
	Analysis 1.1. Comparison 1 Tetracycline vs chloramphenicol, Outcome 1 Febrile after 48 hours.
	Analysis 1.2. Comparison 1 Tetracycline vs chloramphenicol, Outcome 2 Relapse.
	Analysis 2.1. Comparison 2 Doxycycline vs tetracycline, Outcome 1 Febrile after 48 hours.
	Analysis 2.2. Comparison 2 Doxycycline vs tetracycline, Outcome 2 Relapse.
	Analysis 2.3. Comparison 2 Doxycycline vs tetracycline, Outcome 3 Duration of fever.
	Analysis 2.4. Comparison 2 Doxycycline vs tetracycline, Outcome 4 Treatment failure.
	Analysis 3.1. Comparison 3 Rifampicin vs doxycycline, Outcome 1 Febrile after 48 hours.
	Analysis 3.2. Comparison 3 Rifampicin vs doxycycline, Outcome 2 Relapse.
	Analysis 4.1. Comparison 4 High rifampicin dose vs standard rifampicin dose, Outcome 1 Febrile after 48 hours.
	Analysis 4.2. Comparison 4 High rifampicin dose vs standard rifampicin dose, Outcome 2 Relapse.
	Analysis 5.1. Comparison 5 Doxycycline vs standard rifampicin dose vs high rifampicin dose, Outcome 1 Number of participants febrile after 48 hours.
	Analysis 5.2. Comparison 5 Doxycycline vs standard rifampicin dose vs high rifampicin dose, Outcome 2 Median fever clearance time (hours).
	Analysis 5.3. Comparison 5 Doxycycline vs standard rifampicin dose vs high rifampicin dose, Outcome 3 Number of participants with a relapse.
	Analysis 6.1. Comparison 6 Azithromycin vs doxycycline, Outcome 1 Febrile after 48 hours.
	Analysis 6.2. Comparison 6 Azithromycin vs doxycycline, Outcome 2 Relapse.
	Analysis 6.3. Comparison 6 Azithromycin vs doxycycline, Outcome 3 Gastrointestinal side effect.
	Analysis 6.4. Comparison 6 Azithromycin vs doxycycline, Outcome 4 Treatment failure.
	Analysis 7.1. Comparison 7 Telithromycin vs doxycycline, Outcome 1 Duration of fever.
	Analysis 7.2. Comparison 7 Telithromycin vs doxycycline, Outcome 2 Failure.
	Analysis 7.3. Comparison 7 Telithromycin vs doxycycline, Outcome 3 Relapse.
	Analysis 7.4. Comparison 7 Telithromycin vs doxycycline, Outcome 4 Adverse effects.
	Analysis 7.5. Comparison 7 Telithromycin vs doxycycline, Outcome 5 Gastrointestinal side effects.